Multidisciplinary approach for patients with esophageal cancer

Table 1 Randomized trials of neoadjuvant radiation in esophageal cancer

Ref.	Histology	n	Rad dose (Gy)	2-yr survival, %	5-yr survival, %
Launois et al[18]	SCC	57	-	11.5	NR
		67	39-45	9/5	NR
Gignoux et al[17]	SCC	106	-	10	9
		102	33/12	16	10
Wang et al[20]	NR	102	-	33	30
		104	40	37	35
Nygaard et al[19]	SCC	50	-	NR	9 (3 yr)
		58	35 (4 wk)	NR	21 (3 yr)
Arnott et al[16]	SCC	86	-	NR	17
	AC	90	20 (10 d)	NR	9

SCC: Squamous cell carcinoma; NR: Not reported; AC: Adenocarcinoma.